Nasdaq:US$14.66 (+1.21) | HKEX:HK$21.85 (-2.00) | AIM:£2.52 (+0.1)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 30 Nov 2010

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)